Backed by Penn, this startup is seeking FDA approval for its algorithm to save lives after childbirth

By: Holly Quinn | 2 minute read

Outlets: Technical.ly

Published: September 30, 2026

Words: 15

Last Updated: 1 week ago

Vasowatch is building software that works with existing hospital devices to predict postpartum hemorrhage risk.

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.